Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital


Projekt: Typer af projekter

Vis graf over relationer
Primary objective:
To compare the effect of SAR236553 (REGN27) with placebo on the occurrence of cadiovascular events (composite endpoint of coronary heart disease (CHD) death, non-fatal myocardial infarction (MI), fatal and non-fatal ischemic stroke, unstable angina requiring hospitalization) in patients who have experienced an acute coronary syndrom (ACS) event 4 to 16 weeks prior to randomization and are treated with evidence-based medical and dietary management of dyslipidemia.

Secondary objectives:
To evaluate the effect of SAR236553 8REGN27) on secondary endpoints (any CHD event, major CHD event, and CV event, composite of all cause mortality/non-fatal MI/non-fatal ischemic stroke, all cause mortality).

To evaluate the safety and tolerability of SAR236553 (REGN727). To evaluate the effect of SAR236553 (REGN727) on lipid parameters.

ID: 38681896